The total abundance of a protein inside a cell is governed by a dynamic equilibrium: the rate of its synthesis versus the rate of its degradation. When a cellular signal or a drug candidate alters a protein's steady-state level, observing a simple increase or decrease in abundance leaves a fundamental question unanswered: Did the cell change how fast it makes the protein, or how fast it destroys it?
To isolate the kinetics of protein degradation, researchers must decouple it from synthesis. The classic and most widely adopted approach to achieving this is the translation inhibition chase assay, typically executed using cycloheximide (CHX). By freezing the cell’s translation machinery, researchers can observe the pure clearance kinetics of the existing protein pool over time, revealing the protein's intrinsic half-life and how external factors modulate its stability.
Isolating Decay by Silencing Synthesis
In a normal cell, the change in protein concentration over time can be modeled simply as:
$$\frac{d[\text{Protein}]}{dt} = \text{Rate}_{\text{synthesis}} - \text{Rate}_{\text{degradation}}$$
If a genetic mutation or a chemical compound alters the steady-state concentration of a protein, measuring total abundance cannot distinguish between transcriptional/translational changes and post-translational stability.
To isolate the degradation term, researchers introduce a translation inhibitor like cycloheximide. Cycloheximide binds to the E-site of the 60S ribosomal subunit, halting translational elongation. This effectively drives $\text{Rate}_{\text{synthesis}}$ to zero. The equation simplifies to a pure decay function:
$$\frac{d[\text{Protein}]}{dt} = - \text{Rate}_{\text{degradation}}$$
By collecting cell lysates at sequential time points after inhibitor treatment—a process known as the "chase" period—and quantifying the remaining protein via Western blotting or mass spectrometry, researchers can chart an exponential decay curve. The time required for 50% of the initial protein pool to be cleared defines its half-life ($t_{1/2}$).
[Steady State] ---> Add Cycloheximide ---> [Chase Period]
Synthesis = On (Synthesis = Off) Track remaining protein
Degradation = On at 0h, 2h, 4h, 8h...
This fundamental approach allows researchers to determine whether novel compounds or genetic variants alter a protein's metabolic stability. For instance, Youwei Ai et al. utilized CHX chase experiments in An alkaloid initiates phosphodiesterase 3A–schlafen 12 dependent apoptosis without affecting the phosphodiesterase activity to verify whether a novel anti-cancer alkaloid altered the stability of target proteins. Similarly, Rui Zhang et al. applied the assay in The Endoplasmic Reticulum ATP13A1 is Essential for MAVS‐Mediated Antiviral Innate Immunity to demonstrate how the loss of an endoplasmic reticulum protein accelerates the clearance of immune signaling adaptors.
Dissecting Post-Translational Regulation
Once the synthesis background is silenced, the chase assay becomes a powerful diagnostic tool to determine how a protein's lifetime is regulated by its cellular environment. Changes in protein half-life typically point to specific post-translational modifications or molecular interactions.
Identifying Stabilizing Factors
If a protein's half-life elongates during a chase assay, it implies that a molecular partner or modification is shielding it from the cell's clearing machinery.
- Non-coding RNAs: Jing Zhao et al. demonstrated in lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer that the long non-coding RNA GAS5 physically binds to the transcription factor YBX1, protecting it from degradation and extending its half-life to sustain cell-cycle arrest.
- Deubiquitinating Enzymes (DUBs): The covalent attachment of ubiquitin chains often marks proteins for proteasomal destruction. DUBs counteract this by removing the ubiquitin tags. Dian Zhang et al. used CHX chase assays in The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein to show that USP35 prolongs the half-life of the antioxidant regulator NRF2. In a similar fashion, Shijiang Wang et al. proved in USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway that the enzyme USP3 stabilizes the receptor EPHA2, preventing its clearance and keeping downstream growth pathways active.
Identifying Destabilizing Factors
Conversely, a shortened half-life indicates accelerated degradation, often driven by E3 ubiquitin ligases that target the protein for destruction.
- E3 Ligases: Manman Liang et al. utilized CHX chase assays in Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression to show that the presence of the E3 ligase TRIM59 significantly accelerates the decay rate of the tumor suppressor ABHD5.
- Metabolic Shifts: Small-molecule metabolites can also trigger degradation. Chaehyun Yum et al. showed in Ketone drink enhances therapeutic efficacy in prostate cancer by targeting EZH2 that treating cells with a specific ketone body destabilizes the epigenetic regulator EZH2, causing its remaining pool to drop rapidly during a translation-inhibited chase.
Expanding Spatiotemporal Resolution
While the classic cycloheximide chase assay provides a robust bulk measurement of protein half-life, it possesses two major limitations: it kills the cell's metabolic activity by shutting down translation, and it destroys spatial context by requiring cell lysis. Modern variations of the chase concept address these challenges to track degradation kinetics in real time and across complex tissues.
Subcellular and Real-Time Tracking
To understand how proteins degrade within specific compartments of a living cell, researchers swap chemical translation inhibitors for optical tags. As reviewed by Ting Zhao et al. in Subcellular Clearance and Accumulation of Huntington Disease Protein: A Mini-Review, photoconvertible fluorescent proteins (such as Dendra2 or mEos) allow researchers to flash a laser at a precise subcellular region—such as an axon or a dendrite—to change the protein's emission color from green to red. Because newly synthesized proteins will continue to fluoresce green, tracking the decay of the red signal over time acts as a localized, non-toxic chase assay, revealing regional variations in protein clearance.
Taking this concept to a tissue-wide scale, the authors of the DELTA: a method for brain-wide measurement of synaptic protein turnover reveals localized plasticity during learning study developed a pulse-chase imaging framework that measures the ratio between an initial pulse-labeled protein population and a subsequent chase-labeled population. This strategy maps the mean lifetime of synaptic proteins at single-synapse resolution across entire brain regions, capturing how localized learning events accelerate or delay molecular recycling.
Quantifying Degradation in Clinical Proteomics
Outside the living cell, understanding protein degradation kinetics is essential for validating the quality of clinical and post-mortem tissue samples. When a tissue sample is collected, endogenous proteases begin to degrade the proteome, creating a race against time for diagnostic accuracy.
[Intact Tissue] ---> Post-Mortem Interval ---> [Degraded Tissue]
High PIN Score Organ-Specific Decay Low PIN Score
To standardize this, Wenguang Shao et al. established a calibration framework in Comparative analysis of mRNA and protein degradation in prostate tissues indicates high stability of proteins. By exposing cell extracts to incremental protease doses, they mapped specific peptide fragmentation patterns to known physical decay states, creating a metric called the Proteome Integrity Number (PIN).
This focus on tissue-level degradation kinetics is crucial for clinical pathology. As Éva Kocsmár et al. demonstrated in Proteome alterations in human autopsy tissues in relation to time after death, post-mortem protein degradation rates vary dramatically by organ; kidney and liver proteomes undergo significant decay within 48 hours, whereas lung tissue remains highly stable for up to 72 hours. Whether tracking the rapid turnover of an oncogene in a culture dish or mapping the gradual decay of a post-mortem tissue sample, quantifying these degradation kinetics remains central to understanding cellular homeostasis.
Key Foundational Work
lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer (2015) — contributed 1 concept elements to this direction.
Resonance energy transfer for assessing the molecular integrity of proteins for local delivery (2004) — contributed 1 concept elements to this direction.